Macrolide and fluoroquinolone mediated cardiac arrhythmias: clinical considerations and comprehensive review

No abstract is available for this paper.

• Publication year

  2017

• Venue

  Postgraduate medicine

• Publication date

  2017-08-10

• Fields of study

  Medicine

• Identifiers
  DOI 10.1080/00325481.2017.1362938PMID 28770640
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Risk of cardiovascular events, arrhythmia and all-cause mortality associated with clarithromycin versus alternative antibiotics prescribed for respiratory tract infections: a retrospective cohort study

  2017cited by this paper
• Prevalence of Inappropriate Antibiotic Prescriptions Among US Ambulatory Care Visits, 2010-2011

  2016cited by this paper
• An evaluation strategy for potential QTc prolongation with chronic azithromycin therapy in cystic fibrosis.

  2016cited by this paper
• Drug-induced QT interval prolongation and torsades de pointes

  2016cited by this paper
• Prevalence of Inappropriate Antibiotic Prescriptions Among US Ambulatory Care Visits, 2010-2011.

  2016cited by this paper
• Drug safety of macrolide and quinolone antibiotics in a tertiary care hospital: administration of interacting co-medication and QT prolongation

  2016cited by this paper
• Cardiovascular outcomes associated with use of clarithromycin: population based study

  2016cited by this paper
• Macrolide antibiotics and the risk of ventricular arrhythmia in older adults

  2016cited by this paper
• Oral fluoroquinolone use and serious arrhythmia: bi-national cohort study

  2016cited by this paper
• Drug-induced proarrhythmia: risk factors and electrophysiological mechanisms

  2016cited by this paper
• Cardiac risks associated with antibiotics: azithromycin and levofloxacin

  2015cited by this paper
• Part 7: Adult Advanced Cardiovascular Life Support: 2015 American Heart Association Guidelines Update for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care.

  2015cited by this paper
• Risks of cardiac arrhythmia and mortality among patients using new-generation macrolides, fluoroquinolones, and β-lactam/β-lactamase inhibitors: a Taiwanese nationwide study.

  2015cited by this paper
• The Role of Macrolide Antibiotics in Increasing Cardiovascular Risk.

  2015cited by this paper
• The antibiotic resistance crisis: part 1: causes and threats.

  2015cited by this paper
• Cardiac dysrhythmia resulting from antibiotic abuse

  2015cited by this paper
• Macrolide antibiotics and the risk of cardiac arrhythmias.

  2014cited by this paper
• The cardiovascular safety of azithromycin

  2014cited by this paper
• Azithromycin and the Risk of Cardiovascular Complications

  2014cited by this paper
• Erythromycin, QTc interval prolongation, and torsade de pointes: Case reports, major risk factors and illness severity

  2014influential reference
• Azithromycin and Levofloxacin Use and Increased Risk of Cardiac Arrhythmia and Death

  2014cited by this paper
• Clarithromycin, QTc interval prolongation and torsades de pointes: the need to study case reports

  2013cited by this paper
• Use of azithromycin and death from cardiovascular causes.

  2013cited by this paper
• Azithromycin, cardiovascular risks, QTc interval prolongation, torsade de pointes, and regulatory issues: A narrative review based on the study of case reports

  2013cited by this paper
• Azithromycin and risk of sudden cardiac death: Guilty as charged or falsely accused?

  2013influential reference
• KCNE genetics and pharmacogenomics in cardiac arrhythmias: much ado about nothing?

  2013cited by this paper
• QT Prolongation with Antimicrobial Agents

  2012cited by this paper
• Drug-induced QT interval prolongation: mechanisms and clinical management

  2012cited by this paper
• Impact of FDA Drug Risk Communications on Health Care Utilization and Health Behaviors: A Systematic Review

  2012cited by this paper
• Safety Analysis of Fidaxomicin in Comparison With Oral Vancomycin for Clostridium difficile Infections

  2012cited by this paper
• Fluoroquinolones and the risk of serious arrhythmia: a population-based study.

  2012cited by this paper
• Azithromycin and the risk of cardiovascular death.

  2012influential reference
• QT Prolongation and Torsade de Pointes Induced by Fluoroquinolones: Infrequent Side Effects from Commonly Used Medications

  2011cited by this paper
• Azithromycin for prevention of exacerbations of COPD.

  2011cited by this paper
• In-hospital prescription of QT-prolonging drugs in a cohort of more than 100,000 patients.

  2011cited by this paper
• Levofloxacin can be used effectively as a positive control in thorough QT/QTc studies in healthy volunteers.

  2010cited by this paper
• Drug- and non-drug-associated QT interval prolongation.

  2010cited by this paper
• Part 8: adult advanced cardiovascular life support: 2010 American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care.

  2010cited by this paper
• Ciprofloxacin induced acquired long QT syndrome in a patient under class III antiarrhythmic therapy.

  2009cited by this paper
• Latent Genetic Backgrounds and Molecular Pathogenesis in Drug-Induced Long-QT Syndrome

  2009cited by this paper
• Drug‐induced torsades de pointes: data mining of the public version of the FDA Adverse Event Reporting System (AERS)

  2009cited by this paper
• Relation of increased short-term variability of QT interval to congenital long-QT syndrome.

  2009cited by this paper
• IKr channel blockade to unmask occult congenital long QT syndrome

  2008cited by this paper
• I(Kr) channel blockade to unmask occult congenital long QT syndrome.

  2008cited by this paper
• Further evidence of inherited long QT syndrome gene mutations in antiarrhythmic drug-associated torsades de pointes.

  2007cited by this paper
• Infectious Diseases: Safety Concerns with Fluoroquinolones

  2007cited by this paper
• Azithromycin as a cause of QT-interval prolongation and torsade de pointes in the absence of other known precipitating factors

  2007cited by this paper
• Azithromycin-induced QT prolongation in elderly patient.

  2006cited by this paper
• Fundamentals of electrocardiography interpretation.

  2006cited by this paper
• Torsades de pointes induced by antibiotics.

  2006influential reference
• Assessment of the effect of a single oral dose of telithromycin on sotalol-induced qt interval prolongation in healthy women.

  2005cited by this paper
• Polymorphic Ventricular Tachycardia with a Normal QT Interval Following Azithromycin

  2005cited by this paper
• Oral erythromycin and the risk of sudden death.

  2005cited by this paper
• Treatment with clarithromycin prior to coronary artery bypass graft surgery does not prevent subsequent cardiac events.

  2005cited by this paper
• QT prolongation with antimicrobial agents: understanding the significance.

  2004cited by this paper
• Optimal Administration Dosage of Magnesium Sulfate for Torsades de Pointes in Children with Long QT Syndrome

  2004cited by this paper
• Pharmacogenetic Aspects of Drug-Induced Torsade de Pointes

  2004cited by this paper
• Clinical Relevance and Management of Drug‐Related QT Interval Prolongation

  2003cited by this paper
• Torsade de Pointes Due to Noncardiac Drugs: Most Patients Have Easily Identifiable Risk Factors

  2003cited by this paper
• Effects of three fluoroquinolones on QT interval in healthy adults after single doses

  2003cited by this paper
• Effect of single and repeated oral doses of telithromycin on cardiac QT interval in healthy subjects

  2003cited by this paper
• Prescription of QT-prolonging drugs in a cohort of about 5 million outpatients.

  2003cited by this paper
• Telithromycin in the treatment of community-acquired pneumonia: a pooled analysis.

  2003cited by this paper
• Blockade of human cardiac potassium channel human ether-a-go-go-related gene (HERG) by macrolide antibiotics.

  2002cited by this paper
• Safety of fluoroquinolones: An update.

  2002cited by this paper
• Is azithromycin treatment associated with prolongation of the Q-Tc interval?

  2002cited by this paper
• Concomitant risk factors in reports of torsades de pointes associated with macrolide use: review of the United States Food and Drug Administration Adverse Event Reporting System.

  2002cited by this paper
• Cardiotoxicity of macrolides, ketolides and fluoroquinolones that prolong the QTc interval

  2002cited by this paper
• Divergent Proarrhythmic Potential of Macrolide Antibiotics Despite Similar QT Prolongation: Fast Phase 3 Repolarization Prevents Early Afterdepolarizations and Torsade de Pointes

  2002cited by this paper
• Potassium current antagonist properties and proarrhythmic consequences of quinolone antibiotics.

  2001cited by this paper
• Interactions of a series of fluoroquinolone antibacterial drugs with the human cardiac K+ channel HERG.

  2001cited by this paper
• Reassuring safety profile of moxifloxacin.

  2001cited by this paper
• Risk Assessment for Antimicrobial Agent‐Induced QTc Interval Prolongation and Torsades de Pointes

  2001cited by this paper
• [Torsade de pointes and cardiorespiratory arrest induced by azithromycin in a patient with congenital long QT syndrome].

  2001cited by this paper
• Quinolone-induced QT interval prolongation: a not-so-unexpected class effect.

  2001cited by this paper
• Torsade de pointes y parada cardiorrespiratoria inducida por azitromicina en una paciente con síndrome de QT largo congénito

  2001cited by this paper
• Polymorphic ventricular tachycardia, long Q-T syndrome, and torsades de pointes.

  2001cited by this paper
• New classification and update on the quinolone antibiotics.

  2000influential reference
• Comparative Pharmacodynamic Analysis of Q-T Interval Prolongation Induced by the Macrolides Clarithromycin, Roxithromycin, and Azithromycin in Rats

  2000cited by this paper
• Quinolone-induced QT interval prolongation: a not-so-unexpected class effect.

  2000cited by this paper
• The potential for QT prolongation and pro-arrhythmia by non-anti-arrhythmic drugs: clinical and regulatory implications. Report on a Policy Conference of the European Society of Cardiology.

  2000cited by this paper
• Acute eosinophilic hepatitis from trovafloxacin.

  2000cited by this paper
• QTC interval prolongation and polymorphic ventricular tachycardia in association with levofloxacin.

  1999cited by this paper
• Low penetrance in the long-QT syndrome: clinical impact.

  1999cited by this paper
• QTC interval prolongation and polymorphic ventricular tachycardia in association with levofloxacin.

  1999cited by this paper
• QT Interval Prolongation and Torsades de Pointes Due to Erythromycin Lactobionate

  1995cited by this paper
• A molecular basis for cardiac arrhythmia: HERG mutations cause long QT syndrome.

  1995cited by this paper
• Clinical relevance of cardiac arrhythmias generated by afterdepolarizations. Role of M cells in the generation of U waves, triggered activity and torsade de pointes.

  1994cited by this paper
• The fluoroquinolones

  1991cited by this paper
• Torsades de pointes associated with drugs and toxins: recognition and management.

  1987cited by this paper
• Incidence and clinical features of the quinidine-associated long QT syndrome: implications for patient care.

  1986cited by this paper

• Medication association analysis of antimicrobial-induced arrhythmias based on FP-growth frequent pattern mining.

  2026cites this paper
• Traditional Chinese medicine in chronic rhinosinusitis: Mechanisms and postoperative recovery.

  2025cites this paper
• Chinese Guidelines for Diagnosis and Treatment of Chronic Rhinosinusitis (2024)

  2025cites this paper
• Doxycycline for Legionella Pneumonia: Expanding Treatment Horizons Through a Case Series and Narrative Review

  2025cites this paper
• Sorption of ciprofloxacin and enrofloxacin on alkaline cropland soil in semiarid regions: Roles of pH, ionic strength, and ion type.

  2024cites this paper
• A Second Look at Secondary Hypogammaglobulinemia.

  2024cites this paper
• Impact of Azithromycin on the Predisposition to Cardiac Arrhythmias in Adult Patients: A Systematic Review

  2024cites this paper
• Analysis of the effectiveness of combination antimicrobial therapy for Legionnaires' Disease: A nationwide inpatient database study.

  2024cites this paper
• Azithromycin Mechanisms of Action in CRS Include Epithelial Barrier Restoration and Type 1 Inflammation Reduction.

  2023cites this paper
• Acupuncture for chronic rhinosinusitis and Related Postoperative Pain: A systematic review and network meta-analysis

  2022cites this paper
• Seguridad en la selección del tratamiento antibiótico oral en las infecciones comunitarias, más allá de la COVID-19

  2021cites this paper
• Safety review of current systemic treatments for severe chronic rhinosinusitis with nasal polyps and future directions

  2021cites this paper
• Azithromycin-Induced Bradycardia

  2021cites this paper
• Clinical features and mechanistic insights into drug repurposing for combating COVID-19

  2021cites this paper
• European Position Paper on Rhinosinusitis and Nasal Polyps 2020.

  2020influential citation
• [Recommendations for the management of COVID 19 patients regarding proarrhythmic effects of some current treatments, specifically if these patients suffer from arrhythmias, and for those receiving antiarrhythmic therapy.]

  2020cites this paper
• Paroxysmal Atrial Fibrillation Induced by Ciprofloxacin: A Rare Adverse Effect

  2020cites this paper
• Comparative Study of the Effect of Macrolide Antibiotics Erythromycin, Clarithromycin, and Azithromycin on the ERG1 Gene Expression in H9c2 Cardiomyoblast Cells

  2020cites this paper
• Antimicrobial-associated harm in critical care: a narrative review

  2020cites this paper
• Effect of ciprofloxacin vs levofloxacin on QTc‐interval and dysglycemia in diabetic and non‐diabetic patients

  2020cites this paper
• Tres claves para seleccionar el antibiótico oral adecuado en las infecciones respiratorias

  2019cites this paper
• Quinolone antibiotics

  2019cites this paper
• Etiology of community-acquired pneumonia in patients with chronic heart failure

  2019cites this paper
• Oleuropein Curtails Pulmonary Inflammation and Tissue Destruction in Models of Experimental Asthma and Emphysema.

  2018cites this paper
• Outcome Measures in Chronic Rhinosinusitis

  2018cites this paper
• Bronchiectasis: Treatment decisions for pulmonary exacerbations and their prevention

  2018cites this paper
• INVITED REVIEW SERIES: PAEDIATRIC AND ADULT BRONCHIECTASIS

  2018cites this paper
• CHANG Bronchiectasis : Treatment decisions for pulmonary exacerbations and their prevention

  2018cites this paper
• Lower Urinary Tract Infections: An Approach for Greek Community Health Practitioners

  year unknowncites this paper